PFIZER DEAL FOR CYPROTEX

Drug testing specialist Cyprotex has struck a new deal with pharmaceutical giant Pfizer.



The Macclesfield firm`s US-based Apredica subsdiary, which it acquired in 2010, will take part in an 18-month collaborative research project with Pfizer.



The firm said the collaboration was a research-based project which aims to, “evaluate, further develop, and improve several of Cyprotex`s proprietary offerings in the area of predictive toxicology”.